Elke Pogge von Strandmann Selected Research

CD20 Antigens

1/2017	Antigen Loss Variants: Catching Hold of Escaping Foes.
4/2005	Imaging of central nervous system lymphomas with iodine-123 labeled rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elke Pogge von Strandmann Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 04/2005
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 01/2017
3	Leukemia 01/2017 - 01/2016
3	Hodgkin Disease (Hodgkin's Disease) 06/2015 - 09/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020 - 09/2018
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2017 - 05/2013
2	Lymphoma (Lymphomas) 09/2005 - 04/2005
1	Asthma (Bronchial Asthma) 03/2022
1	Inflammation (Inflammations) 11/2021
1	Food Hypersensitivity (Food Allergy) 10/2020
1	Hypersensitivity (Allergy) 10/2020
1	Milk Hypersensitivity (Milk Allergy) 10/2020
1	Adenocarcinoma 09/2018
1	Chronic Pancreatitis 09/2018
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2016
1	Melanoma (Melanoma, Malignant) 01/2016
1	Body Weight (Weight, Body) 06/2015
1	Squamous Cell Carcinoma of Head and Neck 01/2015
1	Infections 06/2013

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 02/2021 - 05/2013
5	Proteins (Proteins, Gene)FDA Link 09/2021 - 01/2014
3	AntigensIBA 01/2017 - 01/2016
3	Monoclonal AntibodiesIBA 01/2015 - 04/2005
2	MicroRNAs (MicroRNA)IBA 03/2022 - 11/2021
2	NK Cell Lectin-Like Receptor Subfamily KIBA 10/2020 - 01/2016
2	LipidsIBA 01/2017 - 01/2014
2	CytokinesIBA 01/2017 - 01/2015
2	CD20 AntigensIBA 01/2017 - 04/2005
2	Natural Killer Cell ReceptorsIBA 01/2016 - 05/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 09/2021
1	Whey ProteinsIBA 10/2020
1	Histones (Histone)IBA 10/2020
1	Immunoglobulin E (IgE)IBA 10/2020
1	PanobinostatIBA 10/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2020
1	Histone Deacetylase InhibitorsIBA 10/2020
1	Small Interfering RNA (siRNA)IBA 10/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2019
1	P-2 (P 2)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	GlypicansIBA 09/2018
1	Phosphotransferases (Kinase)IBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Surface Antigens (Surface Antigen)IBA 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Imatinib Mesylate (Gleevec)FDA Link 01/2017
1	CD30 LigandIBA 05/2016
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2016
1	AFM13IBA 06/2015
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	peptide AIBA 01/2015
1	Cetuximab (Erbitux)FDA Link 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2015
1	Nucleic AcidsIBA 01/2014
1	Galectin 1 (LGALS1)IBA 04/2013
1	Natural Cytotoxicity Triggering Receptor 3IBA 12/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2007
1	HLA-B Antigens (HLA-B)IBA 12/2007
1	NF-kappa B (NF-kB)IBA 09/2005
1	Caspase 1 (ICE Protease)IBA 09/2005
1	Bortezomib (Velcade)FDA Link 09/2005
1	Apoptosis Regulatory ProteinsIBA 09/2005
1	Fas-Associated Death Domain Protein (Fas-Associating Protein with Death Domain)IBA 09/2005
1	Protein CIBA 09/2005
1	Rituximab (Mabthera)FDA Link 04/2005
1	Iodine-123IBA 04/2005

Therapy/Procedure

9	Immunotherapy 09/2021 - 04/2005
4	Therapeutics 01/2017 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2017 - 04/2005
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Induction Chemotherapy 04/2016